JP2012531205A5 - - Google Patents

Download PDF

Info

Publication number
JP2012531205A5
JP2012531205A5 JP2012517731A JP2012517731A JP2012531205A5 JP 2012531205 A5 JP2012531205 A5 JP 2012531205A5 JP 2012517731 A JP2012517731 A JP 2012517731A JP 2012517731 A JP2012517731 A JP 2012517731A JP 2012531205 A5 JP2012531205 A5 JP 2012531205A5
Authority
JP
Japan
Prior art keywords
influenza virus
polypeptide
recombinant
amino acid
reassortant
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2012517731A
Other languages
English (en)
Japanese (ja)
Other versions
JP2012531205A (ja
JP5745511B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2010/039826 external-priority patent/WO2010151673A1/en
Publication of JP2012531205A publication Critical patent/JP2012531205A/ja
Publication of JP2012531205A5 publication Critical patent/JP2012531205A5/ja
Application granted granted Critical
Publication of JP5745511B2 publication Critical patent/JP5745511B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2012517731A 2009-06-25 2010-06-24 ブタインフルエンザヘマグルチニン変異体 Expired - Fee Related JP5745511B2 (ja)

Applications Claiming Priority (9)

Application Number Priority Date Filing Date Title
US22042609P 2009-06-25 2009-06-25
US61/220,426 2009-06-25
US22798609P 2009-07-23 2009-07-23
US61/227,986 2009-07-23
US23402109P 2009-08-14 2009-08-14
US61/234,021 2009-08-14
US25889009P 2009-11-06 2009-11-06
US61/258,890 2009-11-06
PCT/US2010/039826 WO2010151673A1 (en) 2009-06-25 2010-06-24 Swine influenza hemagglutinin variants

Publications (3)

Publication Number Publication Date
JP2012531205A JP2012531205A (ja) 2012-12-10
JP2012531205A5 true JP2012531205A5 (OSRAM) 2013-06-13
JP5745511B2 JP5745511B2 (ja) 2015-07-08

Family

ID=43386887

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2012517731A Expired - Fee Related JP5745511B2 (ja) 2009-06-25 2010-06-24 ブタインフルエンザヘマグルチニン変異体

Country Status (13)

Country Link
US (2) US8088393B2 (OSRAM)
EP (1) EP2448598B1 (OSRAM)
JP (1) JP5745511B2 (OSRAM)
KR (1) KR20120101318A (OSRAM)
CN (1) CN102802666B (OSRAM)
AU (2) AU2010266078B2 (OSRAM)
BR (1) BRPI1014844A2 (OSRAM)
CA (1) CA2766377A1 (OSRAM)
MX (1) MX2012000123A (OSRAM)
NZ (2) NZ596823A (OSRAM)
RU (1) RU2560420C2 (OSRAM)
SG (2) SG176178A1 (OSRAM)
WO (1) WO2010151673A1 (OSRAM)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR20120101318A (ko) 2009-06-25 2012-09-13 메디뮨 엘엘씨 돼지 인플루엔자 헤마글루티닌 변이체
US9017694B2 (en) * 2011-10-07 2015-04-28 Medimmune, Llc Swine influenza hemagglutinin variants
KR101315273B1 (ko) * 2012-10-29 2013-10-08 대한민국 강독화된 인플루엔자 바이러스 변이주
KR20150110494A (ko) * 2012-12-03 2015-10-02 노파르티스 아게 재배열 인플루엔자 a 바이러스
ES2833230T3 (es) 2014-05-13 2021-06-14 Univ Pennsylvania Composiciones que comprenden AVV que expresan construcciones y usos de doble anticuerpo del mismo
US9616114B1 (en) 2014-09-18 2017-04-11 David Gordon Bermudes Modified bacteria having improved pharmacokinetics and tumor colonization enhancing antitumor activity
US10676723B2 (en) 2015-05-11 2020-06-09 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
EP3307310A2 (en) 2015-05-13 2018-04-18 The Trustees Of The University Of Pennsylvania Aav-mediated expression of anti-influenza antibodies and methods of use thereof
US11129906B1 (en) 2016-12-07 2021-09-28 David Gordon Bermudes Chimeric protein toxins for expression by therapeutic bacteria
US11180535B1 (en) 2016-12-07 2021-11-23 David Gordon Bermudes Saccharide binding, tumor penetration, and cytotoxic antitumor chimeric peptides from therapeutic bacteria
JOP20190200A1 (ar) 2017-02-28 2019-08-27 Univ Pennsylvania تركيبات نافعة في معالجة ضمور العضل النخاعي
US11827906B2 (en) 2017-02-28 2023-11-28 The Trustees Of The University Of Pennsylvania Adeno-associated virus (AAV) clade f vector and uses therefor
AU2018229293A1 (en) 2017-02-28 2019-08-29 Janssen Biotech, Inc. Influenza vaccines based on AAV vectors
AU2018392799A1 (en) 2017-12-22 2020-05-28 Codagenix, Inc. Recombinant virus with codon-pair deoptimized region and uses thereof for the treatment of cancer
CA3091508A1 (en) 2018-03-08 2019-09-12 Codagenix Inc. Attenuated flaviviruses
WO2025081053A1 (en) * 2023-10-11 2025-04-17 Flugen, Inc. Formulations for thermostable vaccines

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7871626B2 (en) * 2005-08-04 2011-01-18 St. Jude Children's Research Hospital Modified influenza virus for monitoring and improving vaccine efficiency
WO2007048089A2 (en) * 2005-10-17 2007-04-26 Medimmune, Llc Multi-plasmid system for the production of influenza virus
KR101559184B1 (ko) * 2006-08-09 2015-10-13 메디뮨 엘엘씨 인플루엔자 헤마글루티닌 및 뉴라미니다제 변이체
MX2009013008A (es) * 2007-05-31 2010-06-09 Vacunas para la influenza.
KR20120101318A (ko) 2009-06-25 2012-09-13 메디뮨 엘엘씨 돼지 인플루엔자 헤마글루티닌 변이체

Similar Documents

Publication Publication Date Title
JP2012531205A5 (OSRAM)
RU2012102385A (ru) Варианты гемагглютининов вируса свиного гриппа
Trombetta et al. Challenges in the development of egg-independent vaccines for influenza
Yang et al. Human infection from avian-like influenza A (H1N1) viruses in pigs, China
RU2011104999A (ru) Варианты гемагглютинина и нейрамидазы вируса гриппа
Tewawong et al. Molecular epidemiology and phylogenetic analyses of influenza B virus in Thailand during 2010 to 2014
Evseev et al. Molecular evolution of the influenza A virus non-structural protein 1 in interspecies transmission and adaptation
Jang et al. Principles underlying rational design of live attenuated influenza vaccines
Le Gall-Recule et al. Double introduction of highly pathogenic H5N1 avian influenza virus into France in early 2006
Bashashati et al. Genetic diversity of early (1998) and recent (2010) avian influenza H9N2 virus strains isolated from poultry in Iran
JP2008522621A (ja) 世界的に流行するトリインフルエンザに対して迅速に応答するためのワクチン
Rash et al. An efficient genome sequencing method for equine influenza [H3N8] virus reveals a new polymorphism in the PA-X protein
Fang et al. Molecular epidemiology and evolution of A (H1N1) pdm09 and H3N2 virus during winter 2012–2013 in Beijing, China
Pohuang et al. Sequence analysis of S1 genes of infectious bronchitis virus isolated in Thailand during 2008–2009: identification of natural recombination in the field isolates
Swati et al. Isolation and phylogenetic characterization of Canine distemper virus from India
Looi et al. How far have we reached in development of effective influenza vaccine?
EP2716752A1 (en) Canine influenza recombinant virus, preparation method therefor and application thereof
CN109321535A (zh) 一种热稳定的新城疫病毒弱毒疫苗候选株
Mameli et al. Influenza vaccine response: future perspectives
RU2011137404A (ru) Варианты гемагглютинина и нейраминидазы гриппа
JP2012517239A5 (OSRAM)
Zhou et al. One HA stalk topping multiple heads as a novel influenza vaccine
Hong et al. Comparative genomics of QX-like infectious bronchitis viruses in Korea
Hosseini et al. Phylogenetic analysis of H9N2 avian influenza viruses in Afghanistan (2016-2017)
Yi et al. Molecular characterization of a virulent genotype VIId strain of Newcastle disease virus from farmed chickens in Shanghai